ArticleSurgical endoscopy2025
Outcomes of stepwise treatment of food intolerance secondary to vertical banded gastroplasty.
Article in Surgical endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThere is a high rate of long-term complications and persistent symptoms of food intolerance following Vertical Banded Gastroplasty (VBG). This prompts many patients to undergo difficult revisional bariatric surgery due to inflammation, scarring, and adhesions. Here, we demonstrate the outcomes of treating diet intolerance due to nonadjustable gastric bands (NAGBs) using a stepwise algorithm developed at our institution progressing from endoscopic removal using induced mucosal erosion with a stent (IMES) to a minimally invasive septotomy.
methodsRetrospective chart review was performed on symptomatic patients undergoing stent placement to remove NAGBs at our single institution from 1/1/2018 to 5/6/2024. Patient symptom types and demographic and surgical data were recorded from patient clinical encounters preoperatively and one month after stent removal. Patients with persistent symptoms following NAGB removal were offered restoration of their anatomy via endoscopy-assisted laparoscopic septotomy per our institution's protocol.
resultsTwenty-four patients underwent endoscopic stent placement for gastrointestinal symptoms attributable to a NAGB. One patient did not tolerate stent placement and required stent removal on postoperative day one. Stents were removed between 12 and 28 days for all other patients. Six patients with persistent symptoms after IMES subsequently underwent endoscopy-assisted laparoscopic septotomy without complication and none required additional revisional surgery. The remaining 17 patients (71%) had improvement in their preoperative symptoms and were tolerating a regular diet at one-month follow-up without requiring an additional abdominal operation, which is similar to other published data on endoscopic methods of NAGB removal. There were no complications from stent removal or septotomy.
conclusionOur stepwise treatment of gastrointestinal symptoms secondary to NAGBs is safe and effective. For patients with persistent food intolerance following IMES, there is a safe minimally invasive option in endoscopy-assisted laparoscopic septotomy to avoid more extensive revisional procedures.
Indexed as
Identifiers
40588599What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.